Patterns of Immunohistochemical Expression of P53, BCL2, PTEN, and HER2/neu Tumor Markers in Specific Breast Cancer Lesions

Table 4

Distribution of study subjects by PTEN and Her2/new immunohistochemical expression.

Lesion type	PTEN		Total	Her2/neu		Total
	−Ve	+ve		−Ve	+ve
Carcinoma SBR	0	0	0	1	0	1
Infiltrating DC	3	30	33	39	8	47
Invasive DC	5	85	90	109	24	133
RIDC	0	2	2	1	1	2
Intracystic carcinoma	0	0	0	0	1	1
Ductal carcinoma in situ	1	10	11	3	0	3
MDF adenocarcinoma	0	11	11	2	0	2
PDFC	1	5	6	1	1	2
MANS	1	0	1	1	0	1
Metastatic ductal ca	0	5	5	2	0	2
Invasive lobular ca	0	4	4	6	2	8
Others	5	8	13	0	0	0
Total	16	160	176	165	37	202